Mechanisms of antiparkinsonian action
The pharmacodynamics of amantadine is based on a complex, mixed effect on various neurotransmitter pools in the brain. Three key components of its activity are distinguished:
- Direct dopaminergic mechanism. The drug stimulates the release of endogenous dopamine into the synaptic cleft. Important condition: the process occurs only from intact presynaptic terminals. Additionally, amantadine impairs the reuptake of dopamine by neurons. As a result of these two processes, the concentration of dopamine in the CNS increases significantly, which leads to a reduction in motor symptoms.
- Antiglutamatergic mechanism. The drug acts as an antagonist, blocking NMDA receptors located on cholinergic neurons of the basal ganglia. The blockade prevents the excessive stimulating action of glutamate. This leads to the suppression of cholinergic transmission in the neostriatum and effectively corrects the pathological imbalance between dopamine and acetylcholine.
- Anticholinergic mechanism. In addition to its indirect effect via the glutamate system, the molecule possesses its own, albeit moderately expressed, direct anticholinergic activity.
Neuroprotective potential
In addition to symptomatic control, the drug has the ability to protect nerve cells from death. This neuroprotective effect is also realized through action on the glutamate system.
Amantadine blocks NMDA receptors localized directly on dopaminergic neurons of the substantia nigra. This blockade is critically important because it reduces the excessive influx of calcium ions ($Ca^{2+}$) into the cell. Preventing intracellular calcium overload reliably inhibits the development of excitotoxicity processes, thereby slowing down the destruction and death of neurons.
Clinical profile and safety
In clinical practice, the drug demonstrates a moderate antiparkinsonian effect.
Indications and place in therapy:
- Prescribed for Parkinson's disease and various parkinsonian syndromes.
- Exception: the drug is not used for the treatment of drug-induced parkinsonism.
- It is often used in situations where levodopa is contraindicated for the patient, or prescribed in combination therapy with it to potentiate the effect.
- Important course feature: tolerance to the drug develops quite rapidly, which manifests as a gradual decrease in its therapeutic effect.
Side effects: Adverse reactions are associated with effects on various body systems:
- CNS effects: patients may note agitation, increased irritability, sleep disturbances (insomnia), and dizziness.
- Autonomic and other disorders: orthostatic hypotension may develop, and in severe cases, convulsions.
Briefly: answers to topical questions
What are the contraindications to prescribing amantadine?
Amantadine is not recommended for marked cognitive impairment with a risk of psychosis. The decision to prescribe is made only after neuropsychological testing and evaluation of the cognitive status.
What are the pharmacokinetic features of amantadine?
The pharmacokinetic features of amantadine include a high degree of absorption upon oral administration. The drug is intended for oral administration after meals, with its bioavailability exceeding 90%. Unlike the related rimantadine, which is characterized by intensive metabolism and a long half-life, the pharmacokinetics of amantadine in sources is described briefly, limited to high bioavailability values.
Which groups of antiparkinsonian agents is amantadine combined with?
Amantadine is used in combination with levodopa. Sources also mention the combination of amantadine with an anticholinergic agent when monotherapy is insufficiently effective.
What symptoms are characteristic of acute amantadine overdose?
Amantadine intoxication can trigger hallucinatory-delusional psychoses with schizophreniform symptoms.
The action of amantadine can be remembered through the formula "Plus dopamine, minus glutamate": it RELEASES dopamine from the presynapse and SHIELDS NMDA receptors from calcium.
Class and exam questions
Why does amantadine not treat drug-induced parkinsonism?
Drug-induced parkinsonism is most often caused by the direct blockade of dopamine receptors by neuroleptics, so the enhancement of dopamine release by amantadine cannot overcome this receptor blockade.
What is the neuroprotective action of the drug?
It blocks NMDA receptors on neurons of the substantia nigra, preventing calcium ions from entering the cell in excessive quantities, which prevents excitotoxicity.
What is the main problem with long-term amantadine intake?
The main problem lies in the rapid development of tolerance, due to which the therapeutic antiparkinsonian effect decreases over time.
What else to study on this topic
- Mechanisms of excitotoxicity and the role of calcium ions in neuronal death
- Comparison of the efficacy of amantadine and levodopa preparations
- Principles of combination therapy for Parkinson's disease
- The role of neostriatal cholinergic neurons in movement regulation
- Differences in the pathogenesis of Parkinson's disease versus parkinsonian syndrome
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Amantadine" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.